Girish Putcha

As Freenome’s Chief Medical Officer and Clinical Laboratory Director, Girish oversees the validation of Freenome’s tests and leads policy, reimbursement, regulatory, quality, and scientific/medical affairs initiatives at the company.

Previously, Girish was Director of Laboratory Science for Palmetto’s MolDX program, which oversees coverage and reimbursement for molecular testing for most of the Medicare population, and served as a member of CMS’ Medicare Evidence Development & Coverage Advisory Committee. In prior leadership roles at Life Technologies, Ariosa Diagnostics, and Crescendo Bioscience, he oversaw the development, validation, launch, and commercialization of tests in oncology, fetal-maternal health, and rheumatology. Earlier, he focused on life science investments at Panorama Capital and RiverVest Venture Partners, serving on the boards of portfolio companies, such as Presidio Pharmaceuticals, PowerVision, and Phenomix.

Girish holds an MD, PhD in molecular neuroscience from Washington University in St. Louis, and subspecialized in molecular genetic pathology at Stanford University, where he served as adjunct faculty. He completed undergraduate studies at Rice University, and postgraduate studies at the University of London and the Wellcome Institute for the History of Medicine as a Marshall Scholar.